Sørensen, P.L.; Dittrich, A.L.; Lauridsen, H.L. A Novel Animal Model in Diabetes: Regeneration of β Cells in the Axolotl Salamander? The FASEB Journal 2022, 36, doi:10.1096/fasebj.2022.36.s1.r1914.
Sørensen, P.L.; Dittrich, A.L.; Lauridsen, H.L. A Novel Animal Model in Diabetes: Regeneration of β Cells in the Axolotl Salamander? The FASEB Journal 2022, 36, doi:10.1096/fasebj.2022.36.s1.r1914.
Sørensen, P.L.; Dittrich, A.L.; Lauridsen, H.L. A Novel Animal Model in Diabetes: Regeneration of β Cells in the Axolotl Salamander? The FASEB Journal 2022, 36, doi:10.1096/fasebj.2022.36.s1.r1914.
Sørensen, P.L.; Dittrich, A.L.; Lauridsen, H.L. A Novel Animal Model in Diabetes: Regeneration of β Cells in the Axolotl Salamander? The FASEB Journal 2022, 36, doi:10.1096/fasebj.2022.36.s1.r1914.
Abstract
Diabetes is a group of diseases characterized by loss of β cell mass and/or -function, resulting in hyperglycemia. Approx. 537 million people worldwide suffer from diabetes – a number which is expected to increase. Diabetes is primarily treated by exogenous insulin, which comes with the challenges of maintaining glycemic control to prevent ketoacidosis and severe complications. The need for a curative treatment has initiated the research in β cell regeneration. Several studies in mice have identified essential genes for β cell fate, which can be manipulated in other cells to induce generation of new β cells. Zebrafish, a regeneration-positive animal model, has shown several different sources of new β cells, including regeneration by self-replication, neogenesis by duct-associated progenitor cells, and transdifferentiation of other endocrine islet cells. The animal models used in this research area are either limited by their low regenerative ability (mice), or their small size and remoteness from humans (zebrafish). There is a need for new animal models of diabetes, in which the molecular pathways of endogenous regeneration can be studied. This study proposes the axolotl salamander (Ambystoma mexicanum) as a model for studying the regeneration of β cells. The axolotl has shown great regenerative capability, as they have proven capable of regenerating amputated limbs, and hearts with myocardial infarction, among other organs. This study aims to establish a diabetic axolotl model, investigate their regenerative ability in the pancreas, and examine the potential systemic effects of the induced disease. In a pilot study, five different protocols using STZ (streptozotocin) were tested, and the most optimal protocol was found. Furthermore, the glucose tolerance test was optimized to characterize the glycemic state of the animals. The effect of the treatment on blood glucose levels was measured to characterize the development and decline of the disease. The histological changes in the pancreas were examined. Moreover, the systemic effects of the STZ treatment were investigated in blood and urine. The study indicated that it is possible to induce diabetes in the axolotl, but variations between the animals should be minimized, or the sample size should be increased to conduct a satisfying experiment, as it was not possible to induce diabetes in all animals. Regeneration was not observed histologically, but a restoration of blood glucose levels was seen over the span of the experiment. Lastly, edema formation was observed in some of the STZ-treated animals, but the cause of edema remains undetermined.
Medicine and Pharmacology, Endocrinology and Metabolism
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
